General Medicine — MCQs

General Medicine Indian Medical PG Practice Questions and MCQs

Question 21: Which of the following conditions is not associated with clubbing?

A. Primary biliary cirrhosis
B. Chronic bronchitis (Correct Answer)
C. Cryptogenic fibrosing alveolitis
D. Central bronchiectasis

Explanation: The correct answer is **Chronic bronchitis**. Clubbing is characterized by the focal enlargement of the connective tissue in the terminal phalanges. The underlying pathophysiology usually involves chronic hypoxia, increased vascularity, or the release of growth factors (like PDGF and VEGF) from megakaryocytes that bypass the pulmonary capillary bed. 1. **Why Chronic Bronchitis is the correct answer:** Simple chronic bronchitis is a disease of the large airways and is **not** typically associated with clubbing. Finger clubbing is not a feature of COPD and should trigger further investigation for lung cancer or fibrosis [2]. If clubbing is found in a patient with chronic bronchitis, a clinician must investigate for underlying complications such as bronchiectasis or lung malignancy. 2. **Why the other options are incorrect:** * **Cryptogenic fibrosing alveolitis (Idiopathic Pulmonary Fibrosis):** This is a classic cause of "late-stage" clubbing due to chronic interstitial inflammation and hypoxia [1]. * **Central bronchiectasis:** Suppurative lung diseases (bronchiectasis, lung abscess, empyema) are high-yield causes of clubbing due to chronic infection and increased local blood flow. * **Primary biliary cirrhosis:** This is a well-recognized extra-pulmonary cause of clubbing. It is thought to be related to bile acid metabolism or hepatopulmonary shunting. **High-Yield Clinical Pearls for NEET-PG:** * **Grading of Clubbing:** Grade 1 (Softening of nail bed), Grade 2 (Obliteration of Lovibond’s angle), Grade 3 (Parrot beak appearance), Grade 4 (Drumstick appearance/Hypertrophic Osteoarthropathy). * **Common Causes (Mnemonic: ABCDEF):** **A**bscess (Lung), **B**ronchiectasis, **C**yanotic Heart Disease/CF, **D**on't forget Neoplasia (Bronchogenic Carcinoma), **E**mpyema, **F**ibrosing Alveolitis. * **Unilateral Clubbing:** Think of Axillary artery aneurysm or Brachial plexus injury. * **Differential:** COPD (Emphysema/Bronchitis) does **not** cause clubbing unless there is co-existing malignancy or bronchiectasis [2].

Question 22: In a patient with a smoking history, which factor is most important to assess?

A. Duration of smoking (Correct Answer)
B. Number of cigarettes smoked daily
C. Brand of cigarette
D. Presence of a filter on the cigarette

Explanation: The risk of developing smoking-related complications, particularly **Lung Carcinoma** and **Chronic Obstructive Pulmonary Disease (COPD)**, is most significantly influenced by the **duration of smoking** rather than the intensity (number of cigarettes per day) [1] [2]. According to the **Peto’s Law** and various epidemiological studies, the risk of lung cancer increases proportionally to the intensity of smoking, but it increases to the **fourth or fifth power of the duration** of smoking. For example, doubling the number of cigarettes per day doubles the risk, but doubling the duration of smoking increases the risk approximately 20 to 30 times. Therefore, the chronicity of exposure is the primary determinant of cumulative genetic damage and carcinogenesis. **Analysis of Incorrect Options:** * **B. Number of cigarettes smoked daily:** While this contributes to the "Pack Year" calculation (Packs per day × Years smoked), it is a less potent predictor of malignancy than the total number of years smoked [2]. * **C & D. Brand and Filter:** While "light" cigarettes or filters may slightly alter the concentration of certain tars or nicotine, they do not significantly reduce the risk of major diseases like COPD, MI, or Lung Cancer, as smokers often compensate by inhaling more deeply. **High-Yield Clinical Pearls for NEET-PG:** * **Pack Year Calculation:** (Number of cigarettes smoked per day / 20) × Number of years smoked [2]. * **Smoking Cessation:** The risk of Stroke returns to that of a non-smoker within 5–15 years of quitting. However, the risk for Lung Cancer remains elevated compared to never-smokers for decades, though it halves within 10 years of cessation. * **Most Common Cancer:** Smoking is the leading cause of Small Cell and Squamous Cell Carcinoma of the lung [1].

Question 23: The 'C' wave in the JVP waveform is caused by which of the following events?

A. Atrial contraction
B. Tricuspid valve bulging into the right atrium (Correct Answer)
C. Right atrial filling
D. Rapid ventricular filling

Explanation: The Jugular Venous Pulse (JVP) reflects pressure changes in the right atrium. Understanding its waveform is a high-yield topic for NEET-PG. ### **Explanation of the Correct Answer** The **'c' wave** occurs during **early ventricular systole**. As the right ventricle begins to contract (isovolumetric contraction), the intraventricular pressure rises sharply. This causes the **tricuspid valve to bulge backward into the right atrium**, leading to a transient increase in atrial pressure, which is reflected in the JVP. Additionally, the nearby carotid artery pulsation may contribute to this wave. ### **Analysis of Incorrect Options** * **A. Atrial contraction:** This produces the **'a' wave**. It occurs at the end of diastole and is the first positive deflection. * **C. Right atrial filling:** This occurs while the tricuspid valve is closed during ventricular systole, leading to the **'v' wave**. It represents venous return filling the atrium against a closed valve. * **D. Rapid ventricular filling:** This corresponds to the **'y' descent**. Once the tricuspid valve opens, blood flows rapidly into the ventricle, causing atrial pressure to drop. ### **Clinical Pearls for NEET-PG** * **Giant 'a' waves:** Seen in Tricuspid Stenosis, Pulmonary Hypertension, and Pulmonary Stenosis. * **Cannon 'a' waves:** Seen in AV dissociation (e.g., Complete Heart Block, VT) when the atrium contracts against a closed tricuspid valve. * **Absent 'a' wave:** Pathognomonic for **Atrial Fibrillation**. * **Prominent 'v' wave:** Characteristic of **Tricuspid Regurgitation** (Lancisi’s sign). * **Friedreich’s Sign:** A steep 'y' descent seen in Constrictive Pericarditis.

Question 24: Hepatosplenomegaly is not seen in which of the following conditions?

A. Malaria
B. Lymphoma
C. Sickle cell disease (Correct Answer)
D. Kala azar

Explanation: **Explanation:** The correct answer is **Sickle Cell Disease (SCD)**. While many hematological and infectious conditions cause enlargement of both the liver and spleen, SCD is unique due to the phenomenon of **autosplenectomy** [1]. **1. Why Sickle Cell Disease is the correct answer:** In SCD, repeated episodes of sickling lead to microvascular occlusion and splenic infarction [1]. Over time, the spleen undergoes progressive fibrosis and shrinkage, a process known as autosplenectomy, which is usually complete by late childhood/adolescence [1]. Therefore, while a young child with SCD may have splenomegaly, an adult patient typically has a non-palpable, shrunken spleen. While hepatomegaly may persist, the classic "hepatosplenomegaly" complex is absent. **2. Why the other options are incorrect:** * **Malaria:** Causes massive splenomegaly and moderate hepatomegaly due to chronic hemolysis and hypertrophy of the reticuloendothelial system [2]. * **Lymphoma:** Both Hodgkin and Non-Hodgkin lymphomas frequently involve the liver and spleen through direct infiltration by malignant lymphocytes [3]. * **Kala-azar (Visceral Leishmaniasis):** Characterized by the classic triad of fever, massive splenomegaly, and hepatomegaly due to the proliferation of *Leishmania* amastigotes within the reticuloendothelial cells. **Clinical Pearls for NEET-PG:** * **Massive Splenomegaly (Spleen >8cm):** Remember the mnemonic **"M-C-K"** — **M**yelofibrosis, **C**hronic Myeloid Leukemia (CML), and **K**ala-azar. * **Autosplenectomy:** Howell-Jolly bodies on a peripheral smear are a hallmark sign of functional asplenia/autosplenectomy in SCD [1]. * **SCD Exception:** Splenomegaly *can* be seen in **Sickle-Thalassemia** or **HbSC disease**, where sickling is less severe, preventing early infarction.

Question 25: 20 mEq (mmol) of potassium chloride in 500 ml of 5% dextrose solution is given intravenously to treat which of the following conditions?

A. Metabolic alkalosis (Correct Answer)
B. Respiratory alkalosis
C. Metabolic acidosis
D. Respiratory acidosis

Explanation: ### Explanation **Correct Option: A. Metabolic Alkalosis** The administration of Potassium Chloride (KCl) is the cornerstone of treatment for **Chloride-Responsive Metabolic Alkalosis** (e.g., due to vomiting or diuretic use) [1]. * **The Mechanism:** In metabolic alkalosis, the body often faces a "triple deficit" of fluid, chloride, and potassium. Hypokalemia maintains alkalosis because the kidneys prioritize excreting H+ ions to reabsorb K+ (via H+/K+ ATPase) [1]. Furthermore, chloride depletion forces the kidneys to reabsorb bicarbonate to maintain electrical neutrality. * **The Solution:** Providing KCl (in a carrier like 5% Dextrose or Normal Saline) corrects the chloride deficit, allowing the kidneys to excrete excess bicarbonate, and corrects the potassium deficit, shifting H+ ions back into the extracellular space [1]. **Why the other options are incorrect:** * **B & D (Respiratory Alkalosis/Acidosis):** These are primary disorders of ventilation ($CO_2$ imbalance). Treatment focuses on addressing the underlying pulmonary cause or adjusting ventilator settings, not electrolyte replacement. * **C (Metabolic Acidosis):** This condition is characterized by a low pH. Adding KCl does not address the acid-base imbalance; in fact, severe acidosis often causes *hyperkalemia* (as H+ moves intracellularly and K+ moves out), making potassium administration potentially dangerous. **High-Yield NEET-PG Pearls:** * **Saline-Responsive Alkalosis:** Defined by Urinary Chloride **< 20 mEq/L**. It responds to NaCl or KCl [1]. * **Saline-Resistant Alkalosis:** Defined by Urinary Chloride **> 20 mEq/L** (e.g., Conn’s syndrome, Bartter’s). It does not respond to simple saline/KCl infusion. * **Infusion Rate:** Never exceed **10–20 mEq/hour** of peripheral IV potassium to avoid cardiotoxicity. * **Paradoxical Aciduria:** Seen in metabolic alkalosis where the kidney excretes H+ despite systemic alkalosis due to volume/K+ depletion. KCl corrects this [1].

Question 26: Which of the following conditions is associated with an increase in Lactate Dehydrogenase (LDH) levels?

A. Bulky disease (Correct Answer)
B. Lymphoma
C. Liver metastasis
D. Lung metastasis

Explanation: **Explanation:** Lactate Dehydrogenase (LDH) is a non-specific intracellular enzyme found in almost all body tissues. It serves as a marker of **high cell turnover, tissue destruction, or metabolic activity** [1]. **Why "Bulky Disease" is the most appropriate answer:** In the context of oncology, "Bulky disease" refers to a large tumor mass (typically >10 cm in diameter). High LDH levels in these patients are a direct reflection of the **total tumor burden** [3]. Large tumors often have areas of central necrosis and rapid cellular proliferation, leading to the massive release of LDH into the bloodstream. In clinical practice, LDH is used as a crucial prognostic marker in the **IPI (International Prognostic Index)** for lymphomas, where it correlates specifically with the extent (bulk) of the disease [2]. **Analysis of Other Options:** * **B, C, and D (Lymphoma, Liver, and Lung Metastasis):** While LDH can indeed be elevated in these conditions, they are specific manifestations or sites of disease. The question asks for the condition most fundamentally *associated* with the increase. "Bulky disease" is the overarching clinical concept that explains *why* LDH rises in lymphoma or metastatic states—it signifies the volume of the pathology rather than just its location [3]. **NEET-PG High-Yield Pearls:** * **Tumor Marker:** LDH is a key marker for **Germ Cell Tumors** (especially Dysgerminoma) and **Ewing’s Sarcoma** [3]. * **Pneumocystis jirovecii (PJP):** Elevated LDH in an HIV-positive patient with respiratory distress is a classic diagnostic clue for PJP pneumonia. * **Hemolysis:** LDH is a sensitive marker for intravascular hemolysis (e.g., HUS, TTP, or Megaloblastic anemia). * **Megaloblastic Anemia:** Characterized by the highest levels of LDH (often >3000 U/L) due to ineffective erythropoiesis.

Question 27: Which of the following statements regarding obesity is true?

A. Dexenfluramine is the drug of choice.
B. Sibutramine is an epinephrine uptake inhibitor.
C. According to WHO, a body mass index greater than 25 is considered overweight. (Correct Answer)
D. The long-term effects of Orlistat are well-known.

Explanation: ### Explanation **Correct Option: C** The World Health Organization (WHO) classifies weight status based on Body Mass Index (BMI), calculated as weight in kilograms divided by the square of height in meters ($kg/m^2$) [1]. According to these criteria: * **Overweight:** BMI $\geq$ 25 * **Obesity:** BMI $\geq$ 30 * **Underweight:** BMI < 18.5 *(Note: For the Asian-Indian population, the cutoff for overweight is lower, at $\geq$ 23 $kg/m^2$.)* **Analysis of Incorrect Options:** * **Option A:** **Dexfenfluramine** is no longer the drug of choice; it was withdrawn from the market globally due to its association with valvular heart disease and pulmonary hypertension. * **Option B:** **Sibutramine** is a combined norepinephrine, serotonin, and dopamine reuptake inhibitor (SNRI), not just an epinephrine uptake inhibitor. However, it was also withdrawn due to increased risks of cardiovascular events (SCOUT trial). * **Option D:** While **Orlistat** (a gastric and pancreatic lipase inhibitor) is FDA-approved for long-term use, the statement is generally considered false in a clinical exam context because "well-known long-term effects" often implies safety [2]. However, Orlistat is frequently limited by GI side effects (steatorrhea) and potential malabsorption of fat-soluble vitamins. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Currently, **Liraglutide** (GLP-1 agonist) or **Semaglutide** are highly preferred for pharmacological management. * **Bariatric Surgery Indications:** BMI $\geq$ 40 or BMI $\geq$ 35 with comorbidities (e.g., Type 2 DM, OSA) [2]. * **Pickwickian Syndrome:** Also known as Obesity Hypoventilation Syndrome, characterized by the triad of obesity, sleep apnea, and hypercapnia. * **Waist Circumference:** A better predictor of visceral fat and metabolic risk than BMI (High risk: $>102$ cm in men, $>88$ cm in women).

Question 28: A 35-year-old man presents with acute onset of pain, swelling, and redness of his right big toe as shown in the image. What is the most likely diagnosis?

A. Cellulitis
B. Deep vein thrombosis
C. Gout (Correct Answer)
D. Polyarteritis nodosa

Explanation: ***Gout*** - **Acute monoarthritis** of the **first metatarsophalangeal joint** (big toe) with **erythema** and **swelling** is the classic presentation of **podagra**, the hallmark of gout. - **Sudden onset** pain and inflammation in the big toe, especially in men aged 30-50, strongly suggests **uric acid crystal deposition** causing acute gouty arthritis. *Cellulitis* - Would present with **spreading erythema** and **warmth** extending beyond the joint boundaries, often with **lymphangitis** or **fever**. - Typically affects **soft tissues** rather than causing discrete joint swelling, and pain would be more **diffuse** rather than localized to the joint. *Deep vein thrombosis* - Primarily affects **leg veins** causing **calf pain** and swelling, not isolated **toe joint involvement**. - Presents with **unilateral leg edema**, **warmth**, and **positive Homan's sign**, which are absent in this case. *Polyarteritis nodosa* - A **systemic vasculitis** affecting **medium-sized arteries** with multi-organ involvement including skin, kidneys, and nerves. - Would present with **systemic symptoms** like fever, weight loss, and **multiple organ dysfunction**, not isolated joint inflammation.

Question 29: The second heart sound (S2) is best appreciated in which of the following areas?

A. Third left intercostal space (Correct Answer)
B. Second right intercostal space
C. Fourth left intercostal space
D. Fifth left intercostal space

Explanation: ### Explanation The **second heart sound (S2)** is produced by the closure of the semilunar valves (Aortic and Pulmonary) at the beginning of ventricular diastole [1]. **Why Option A is Correct:** While the aortic component (A2) is traditionally heard at the 2nd right intercostal space and the pulmonary component (P2) at the 2nd left intercostal space, the **Third left intercostal space (Erb’s point)** is the location where S2 is best appreciated as a whole. At this site, the sounds from both semilunar valves converge, making it the optimal area to evaluate the intensity and splitting (physiologic or pathologic) of S2. **Analysis of Incorrect Options:** * **Option B (Second right intercostal space):** This is the **Aortic area** [2]. While A2 is loud here, it is not the best place to hear the combined S2 or to appreciate the splitting between A2 and P2. * **Option C (Fourth left intercostal space):** This is the **Tricuspid area**, where the first heart sound (S1) and right-sided murmurs (e.g., Tricuspid Regurgitation) are better heard. * **Option D (Fifth left intercostal space):** This is the **Mitral area (Apex)**. It is the best site for hearing S1 and murmurs like Mitral Stenosis or Regurgitation [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Physiologic Splitting:** S2 splits during inspiration (increased venous return delays P2) and fuses during expiration. * **Wide Fixed Splitting:** Pathognomonic for **Atrial Septal Defect (ASD)**. * **Paradoxical Splitting:** Occurs when P2 precedes A2; seen in **Left Bundle Branch Block (LBBB)** and **Aortic Stenosis**. * **Loud P2:** A classic sign of **Pulmonary Hypertension** [2].

Question 30: Which of the following is not associated with zinc deficiency?

A. Delayed wound healing
B. Loss of libido
C. Pigmentation (Correct Answer)
D. Sexual infantilism

Explanation: **Explanation:** Zinc is an essential trace element required for the function of over 300 enzymes, including DNA polymerase and alkaline phosphatase [1]. It plays a critical role in protein synthesis, cell division, and immune function. **Why Pigmentation is the Correct Answer:** Zinc deficiency is typically associated with **hypopigmentation** (loss of pigment) rather than hyperpigmentation. In conditions like **Acrodermatitis Enteropathica**, patients present with erythematous, vesiculobullous, and eczematous lesions, often accompanied by alopecia [1]. Pigmentation (hyperpigmentation) is more characteristic of other nutritional deficiencies, such as Vitamin B12 or Niacin (Pellagra) [2]. **Analysis of Incorrect Options:** * **Delayed wound healing:** Zinc is a cofactor for enzymes involved in collagen synthesis and cell proliferation. Deficiency impairs the inflammatory phase and epithelialization, leading to poor wound healing [1]. * **Loss of libido and Sexual infantilism:** Zinc is vital for the development and function of the reproductive system. It is necessary for testosterone synthesis and spermatogenesis. Severe deficiency leads to hypogonadism, delayed puberty (sexual infantilism), and decreased libido [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Acrodermatitis Enteropathica:** An autosomal recessive disorder causing zinc malabsorption. Classic triad: **Dermatitis** (periorificial and acral), **Alopecia**, and **Diarrhea** [1]. * **Immune Impact:** Zinc deficiency causes thymic atrophy and impaired T-cell function, leading to increased susceptibility to infections [1]. * **Other Features:** Dysgeusia (distorted sense of taste), anosmia, and night blindness (zinc is required for Retinol Binding Protein synthesis). * **Diagnosis:** Low serum zinc levels (though clinical response to supplementation is often the gold standard).

Practice by Chapter

Approach to the Medical Patient

Practice Questions

Differential Diagnosis Development

Practice Questions

Rational Diagnostic Testing

Practice Questions

Medical Decision Making

Practice Questions

Cost-effective Care

Practice Questions

Patient-centered Communication

Practice Questions

Interprofessional Collaboration

Practice Questions

Systems-based Practice

Practice Questions

High-value Care

Practice Questions

Transitions of Care

Practice Questions

Chronic Disease Management

Practice Questions

Medical Uncertainty Management

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free